PDS Biotechnology share price logo

PDS Biotechnology

NASDAQ: PDSB

$1.44

-0.11

(-7.10%)

as on

PDS Biotechnology Stock Performance

as on October 31, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.33
    $1.55
    downward going graph

    7.64%

    Downside

    7.64%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.20
    $1.79
    downward going graph

    86.44%

    Downside

    24.31%

    Upside

    downward going graph

PDS Biotechnology share price movements today

Previous Close
$1.55
Open
$1.47
Volume
5.7M
Market Cap
$159.6M
Day's Low - High
$1.33 - $1.55
52 Week Low - High
$0.20 - $1.79

PDS Biotechnology Historical Returns

1 Month Return
+ 106.47 %
3 Month Return
+ 121.75 %
1 Year Return
+ 63.16 %
3 Year Return
-63.1 %
5 Year Return
-87.13 %

PDS Biotechnology Stock Fundamentals & Key Indicators

Check PDS Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$159.6M

EPS (TTM)

-0.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.38

Industry PE ratio

-3.27

PEG Ratio

-0.06

EBITDA

-27.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-708.20%

PDS Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PDS Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
PDS Biotechnology image
PDS Biotechnology
Buy$159.6M-87.13%-2.380.00%0.00%
Moderna image
Moderna
Neutral$85.5B-35.47%-26.84-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$134.2B192.00%30.5886.04%0.00%
Regeneron image
Regeneron
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for PDS Biotechnology Stock including INR - Dollar returns

The PDS Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

PDS Biotechnology investment value today

Current value as on today

₹1,62,384

Returns

₹62,384

(+62.38%)

Returns from PDS Biotechnology Stock

₹51,579 (+51.58%)

Dollar Impact

₹10,805 (+10.81%)

Analyst Recommendation on PDS Biotechnology Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for PDS Biotechnology. Average target price of $5

PDS Biotechnology Share Price Target

Get share price movements and forecasts by analysts on PDS Biotechnology.

What analysts predicted

71.2%UPSIDE

Target Price

$5

Current Price

$1.44

Analyzed by

2 Analysts

High

$5

Target

$5.00

Low

$4

PDS Biotechnology target price $5, a slight upside of 71.2% compared to current price of $1.44. According to 2 analysts rating.

Indian Investors' Interest in PDS Biotechnology Stock

Investment in PDS Biotechnology Shares on INDmoney has grown by 58.85% in the last 30 days, indicating increased investment activity.

Time period: to

Change:58.85% versus previous 30 day period

Search interest for PDS Biotechnology Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

PDS Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
-
-
-
-
-
Operating Income
-10
-8
-10
-7
-9
-7
-8
-6
-6
-6
EBITDA
-9
-8
-9
-6
-8
-7
-7
-6
-6
-6
Interest Expense
1
1
1
1
0
2
1
1
1
3
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-9
-10
-7
-9
-9
-9
-7
-7
-9
Income Tax Expense
-
0
-
-
-1
-
-
-
-
-
Net Income
-10
-8
-10
-7
-8
-9
-9
-7
-7
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PDS Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
0
0
-
Operating Income
-51
-43
-15
-14
-21
-41
-43
-36
-31
EBITDA
-51
-3
-7
-14
-21
-40
-40
-12
-30
Interest Expense
2
1
0
-
-
1
4
4
5
Depreciation
0
0
0
0
0
0
0
21
0
Income Before Tax
-53
-3
-7
-14
-21
-42
-44
-38
-35
Income Tax Expense
-2
-2
0
-
-4
-1
-1
0
-1
Net Income
-50
-40
-6
-14
-16
-40
-42
-37
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PDS Biotechnology Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-8
-10
-7
-8
-9
-9
18,822
-7
-9
Operating Cash Flow
-9
-8
-7
-8
-9
-9
-5
-3
-4
-2
Investing Cash Flow
-
0
0
-
-
-
-
-
-
-
Financing Cash Flow
20
0
0
0
7
0
0
4
0
-13
Change in Cash
10
-8
-7
-8
-1
-8
-5
0
-5
-16

PDS Biotechnology Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-40
-6
-14
-16
-40
-42
-37
-34
Operating Cash Flow
-40
-33
-18
-13
-12
-25
-33
-35
-27
Investing Cash Flow
0
-
29
-
-
-
-
0
-
Financing Cash Flow
22
-20
0
29
48
34
16
20
12
Change in Cash
-18
-53
12
16
36
8
-17
-14
-14

Global Institutional Holdings in PDS Biotechnology

Check out the Institutions with significant holdings in PDS Biotechnology.

Funds
Holdings
VANGUARD INDEX FUNDS
1.55%
Vanguard
1.55%
Fidelity Concord Street Trust
0.48%
iShares
0.16%
TIAA-CREF Funds
0.10%
See all

PDS Biotechnology News & Key Events

  • img

    Today's Timeline - 14 October

    Wed, 08:30 PM

    -

    PDS Biotechnology upgraded to Zacks Rank #2 (Buy) due to rising earnings estimates, indicating positive business outlook.

    Thu, 01:50 AM

    -

    PDS Biotechnology registers to sell 16.5M shares of common stock by selling stockholders; company won't receive proceeds.

Insights on PDS Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PDSB stock has moved up by 39.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 628.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 200.7% return, outperforming this stock by 263.8%

About PDS Biotechnology

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.
OrganisationPDS Biotechnology
Headquarters303A College Road East, Princeton, NJ, 08540, US
IndustryBiotechnology
CEOFrank K. Bedu-Addo

Key Management of PDS Biotechnology

Name

Title

Dr. Gregory L. Conn Ph.D.

Chief Scientific Officer

Mr. Spencer Brown J.D.

Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer

Dr. Kirk V. Shepard M.D.

Chief Medical Officer

Ms. Janetta Trochimiuk

Controller & Interim Principal Accounting Officer

FAQs

What is PDS Biotechnology share price today?

PDS Biotechnology share price today is $1.44 as on at the close of the market. PDS Biotechnology share today touched a day high of $1.55 and a low of $1.33.

What is the 52 week high and 52 week low for PDS Biotechnology share?

PDS Biotechnology share touched a 52 week high of $1.79 on and a 52 week low of $0.20 on . PDS Biotechnology stock price today i.e. is closed at $1.44,which is 19.55% down from its 52 week high and 637.70% up from its 52 week low.

What is PDS Biotechnology's market capitalisation today?

PDS Biotechnology market capitalisation is $0.00T as on .

How to invest in PDS Biotechnology Stock (PDSB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PDS Biotechnology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy PDS Biotechnology Stock (PDSB) from India?

Indian investors can start investing in PDS Biotechnology (PDSB) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in PDS Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on PDS Biotechnology share’s latest price of $1.44 as on October 31, 2026 at 1:29 am IST, you will get 6.9444 shares of PDS Biotechnology. Learn more about fractional shares .

What are the returns that PDS Biotechnology has given to Indian investors in the last 5 years?

PDS Biotechnology stock has given -87.13% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?